Literature DB >> 2862458

Disturbance of blood-brain barrier after bone-marrow transplantation.

J P Sloane, K Y Lwin, M E Gore, R L Powles, J F Smith.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 2862458     DOI： 10.1016/s0140-6736(85)90335-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation.

Authors:  J-S Claveau; R LeBlanc; I Ahmad; J Ferreira; A-A Pistono; N Bambace; L Bernard; S Cohen; J-S Delisle; T Kiss; S Lachance; J Roy
Journal:  Bone Marrow Transplant       Date:  2017-07-10       Impact factor: 5.483

3.  Cyclosporin neurotoxicity in cardiac transplant recipients.

Authors:  R J Lane; S W Roche; A A Leung; A Greco; L S Lange
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

4.  Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.

Authors:  W S Bartynski; Z Zeigler; M P Spearman; L Lin; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

5.  Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

6.  Posterior reversible encephalopathy in a child with Langerhans cell histiocytosis following allogeneic PBSCT treatment with cyclosporine.

Authors:  Chi-Chieh Lai; Shyi-Jou Chen; Shao-Hung Lien; Chung-Ping Lo; Shin-Nang Cheng
Journal:  Eur J Pediatr       Date:  2007-07-26       Impact factor: 3.183

7.  RAS in Pregnancy and Preeclampsia and Eclampsia.

Authors:  M Rodriguez; J Moreno; J Hasbun
Journal:  Int J Hypertens       Date:  2012-12-30       Impact factor: 2.420
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.